Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 7 | 2022 | 85 | 2.090 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 128 | 1.810 |
Why?
|
| Proteome | 5 | 2023 | 38 | 1.490 |
Why?
|
| RNA, Messenger | 3 | 2022 | 284 | 1.380 |
Why?
|
| Transcriptome | 7 | 2023 | 74 | 1.370 |
Why?
|
| Alzheimer Disease | 11 | 2023 | 1962 | 1.290 |
Why?
|
| Algorithms | 3 | 2023 | 347 | 1.210 |
Why?
|
| Cognitive Dysfunction | 7 | 2023 | 1017 | 0.910 |
Why?
|
| Brain | 10 | 2023 | 1560 | 0.870 |
Why?
|
| Dementia | 3 | 2022 | 532 | 0.760 |
Why?
|
| Sjogren's Syndrome | 2 | 2020 | 3 | 0.750 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 23 | 0.660 |
Why?
|
| Histones | 1 | 2019 | 27 | 0.660 |
Why?
|
| Blood Proteins | 1 | 2018 | 18 | 0.610 |
Why?
|
| ErbB Receptors | 2 | 2010 | 52 | 0.610 |
Why?
|
| Methotrexate | 1 | 2018 | 34 | 0.600 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 79 | 0.570 |
Why?
|
| Immunophenotyping | 1 | 2017 | 26 | 0.570 |
Why?
|
| Epigenomics | 1 | 2017 | 13 | 0.570 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 23 | 0.560 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 29 | 0.550 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 264 | 0.510 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 238 | 0.500 |
Why?
|
| Models, Genetic | 1 | 2015 | 30 | 0.480 |
Why?
|
| Humans | 26 | 2023 | 25692 | 0.380 |
Why?
|
| Phosphoproteins | 1 | 2010 | 24 | 0.360 |
Why?
|
| Aged | 11 | 2023 | 8501 | 0.350 |
Why?
|
| Amyloid beta-Peptides | 5 | 2023 | 315 | 0.310 |
Why?
|
| Models, Biological | 2 | 2010 | 311 | 0.300 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 155 | 0.300 |
Why?
|
| Mass Spectrometry | 2 | 2022 | 38 | 0.290 |
Why?
|
| Aged, 80 and over | 8 | 2023 | 4459 | 0.260 |
Why?
|
| Male | 13 | 2023 | 13917 | 0.250 |
Why?
|
| Prefrontal Cortex | 3 | 2023 | 145 | 0.250 |
Why?
|
| Cognition | 4 | 2023 | 1265 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 351 | 0.240 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 39 | 0.230 |
Why?
|
| Female | 11 | 2023 | 14273 | 0.230 |
Why?
|
| Cluster Analysis | 1 | 2023 | 39 | 0.220 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 2 | 0.220 |
Why?
|
| Benchmarking | 1 | 2023 | 37 | 0.220 |
Why?
|
| Phosphorylation | 4 | 2017 | 134 | 0.200 |
Why?
|
| Neurofibrillary Tangles | 2 | 2023 | 182 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 19 | 0.200 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 4 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 110 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 19 | 0.190 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2020 | 2 | 0.180 |
Why?
|
| Peptides | 1 | 2021 | 104 | 0.180 |
Why?
|
| Schizophrenia | 2 | 2011 | 62 | 0.180 |
Why?
|
| Movement Disorders | 1 | 2021 | 82 | 0.170 |
Why?
|
| tau Proteins | 4 | 2023 | 219 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2023 | 210 | 0.170 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 262 | 0.170 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 201 | 0.170 |
Why?
|
| Acetylation | 1 | 2019 | 13 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 26 | 0.160 |
Why?
|
| Pyrimidines | 2 | 2017 | 21 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2019 | 52 | 0.160 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 72 | 0.160 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 3 | 0.150 |
Why?
|
| Infliximab | 1 | 2018 | 15 | 0.150 |
Why?
|
| Seasons | 1 | 2018 | 23 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2019 | 150 | 0.150 |
Why?
|
| Genotype | 1 | 2019 | 326 | 0.150 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 1176 | 0.150 |
Why?
|
| Cell Count | 1 | 2018 | 66 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.150 |
Why?
|
| Remission Induction | 1 | 2018 | 80 | 0.150 |
Why?
|
| Monocytes | 1 | 2018 | 53 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2018 | 57 | 0.150 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2019 | 108 | 0.150 |
Why?
|
| Neutrophils | 1 | 2018 | 89 | 0.150 |
Why?
|
| Phenotype | 3 | 2023 | 292 | 0.150 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 84 | 0.150 |
Why?
|
| Computational Biology | 1 | 2017 | 19 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2010 | 183 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2017 | 17 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 16 | 0.140 |
Why?
|
| ADAM Proteins | 1 | 2017 | 39 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 25 | 0.140 |
Why?
|
| Motor Activity | 1 | 2019 | 304 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 45 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2018 | 532 | 0.130 |
Why?
|
| Imidazoles | 1 | 2017 | 53 | 0.130 |
Why?
|
| Chicago | 1 | 2019 | 869 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2010 | 410 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 103 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1300 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2023 | 776 | 0.120 |
Why?
|
| Markov Chains | 1 | 2015 | 29 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 52 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2015 | 39 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 913 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 52 | 0.120 |
Why?
|
| Epidermal Growth Factor | 2 | 2010 | 27 | 0.110 |
Why?
|
| Risk Factors | 1 | 2019 | 2224 | 0.110 |
Why?
|
| Aging | 2 | 2019 | 1429 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2019 | 965 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 37 | 0.100 |
Why?
|
| Adult | 3 | 2023 | 7336 | 0.090 |
Why?
|
| Middle Aged | 4 | 2018 | 8403 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 23 | 0.090 |
Why?
|
| Tyrosine | 1 | 2010 | 25 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 23 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 7 | 0.090 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2010 | 9 | 0.090 |
Why?
|
| Linear Models | 2 | 2023 | 231 | 0.090 |
Why?
|
| Gene Expression | 2 | 2023 | 182 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2010 | 140 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 259 | 0.090 |
Why?
|
| Cell Line | 1 | 2010 | 268 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3231 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 325 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 1 | 0.080 |
Why?
|
| Animals | 2 | 2019 | 3510 | 0.080 |
Why?
|
| Neurons | 2 | 2021 | 315 | 0.070 |
Why?
|
| Computer Graphics | 1 | 2006 | 6 | 0.060 |
Why?
|
| Software | 1 | 2006 | 63 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 179 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2023 | 11 | 0.060 |
Why?
|
| Base Sequence | 1 | 2023 | 90 | 0.060 |
Why?
|
| DNA | 1 | 2023 | 95 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 1781 | 0.050 |
Why?
|
| Organ Size | 1 | 2023 | 103 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 13 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2023 | 9 | 0.050 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Adaptor Protein Complex beta Subunits | 1 | 2023 | 7 | 0.050 |
Why?
|
| Mitochondria | 1 | 2023 | 62 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 36 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2023 | 37 | 0.050 |
Why?
|
| Neuropathology | 1 | 2023 | 84 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 56 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 190 | 0.050 |
Why?
|
| Germinal Center | 1 | 2020 | 1 | 0.040 |
Why?
|
| SOXC Transcription Factors | 1 | 2020 | 1 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 50 | 0.040 |
Why?
|
| Thy-1 Antigens | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 3 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 9 | 0.040 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 26 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 89 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 65 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 217 | 0.040 |
Why?
|
| Microglia | 1 | 2019 | 133 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 138 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 111 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 341 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 12 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2019 | 79 | 0.040 |
Why?
|
| Memory, Episodic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 313 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 2019 | 171 | 0.040 |
Why?
|
| Memory | 1 | 2019 | 296 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 82 | 0.040 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2019 | 101 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 366 | 0.040 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 244 | 0.040 |
Why?
|
| Hippocampus | 1 | 2019 | 262 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2017 | 11 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 35 | 0.030 |
Why?
|
| Exons | 1 | 2017 | 29 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 36 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 72 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 100 | 0.030 |
Why?
|
| Astrocytes | 1 | 2018 | 141 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 329 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 316 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 584 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1633 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 554 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 847 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 1345 | 0.030 |
Why?
|
| Coenzyme A Ligases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 17 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 17 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 111 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 140 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 75 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 7 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 221 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1336 | 0.010 |
Why?
|